MacroGenics To Initiate Phase II Trial Of Teplizumab For Type 1 Diabetes
This article was originally published in The Pink Sheet Daily
Executive Summary
CEO discusses details of the study and future areas of research in an interview with “The Pink Sheet” DAILY.